- Home
- DSGX vs ASND Comparison
DSGX vs ASND Comparison
Compare DSGX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGX
- ASND
- Stock Information
- Founded
- DSGX 1981
- ASND 2006
- Country
- DSGX Canada
- ASND Denmark
- Employees
- DSGX N/A
- ASND N/A
- Industry
- DSGX Computer Software: Prepackaged Software
- ASND Biotechnology: Pharmaceutical Preparations
- Sector
- DSGX Technology
- ASND Health Care
- Exchange
- DSGX Nasdaq
- ASND Nasdaq
- Market Cap
- DSGX 9.0B
- ASND 10.6B
- IPO Year
- DSGX 1999
- ASND 2015
- Fundamental
- Price
- DSGX $104.30
- ASND $195.58
- Analyst Decision
- DSGX Buy
- ASND Strong Buy
- Analyst Count
- DSGX 8
- ASND 16
- Target Price
- DSGX $123.25
- ASND $240.75
- AVG Volume (30 Days)
- DSGX 468.4K
- ASND 413.2K
- Earning Date
- DSGX 09-03-2025
- ASND 08-07-2025
- Dividend Yield
- DSGX N/A
- ASND N/A
- EPS Growth
- DSGX 14.17
- ASND N/A
- EPS
- DSGX 1.69
- ASND N/A
- Revenue
- DSGX $684,781,000.00
- ASND $576,332,355.00
- Revenue This Year
- DSGX $10.78
- ASND $101.37
- Revenue Next Year
- DSGX $14.47
- ASND $76.17
- P/E Ratio
- DSGX $61.91
- ASND N/A
- Revenue Growth
- DSGX 12.69
- ASND 54.50
- 52 Week Low
- DSGX $92.00
- ASND $111.09
- 52 Week High
- DSGX $124.31
- ASND $208.16
- Technical
- Relative Strength Index (RSI)
- DSGX 53.46
- ASND 52.37
- Support Level
- DSGX $105.38
- ASND $196.06
- Resistance Level
- DSGX $108.09
- ASND $202.57
- Average True Range (ATR)
- DSGX 2.53
- ASND 6.49
- MACD
- DSGX 0.72
- ASND -0.82
- Stochastic Oscillator
- DSGX 57.85
- ASND 34.34
About DSGX Descartes Systems Group Inc. (The)
Descartes Systems Group provides a software solution that allows users in the shipping industry to communicate with one another. Its core product is the Global Logistics Network, which is best understood as transaction-driven. Descartes charges clients to send/receive messages, data, and documents on the GLN. Customers typically contract for a monthly minimum over a multiyear period. The GLN platform allows Descartes to upsell additional software modules as well, typically provided via a software-as-a-service model.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.